• Nigeria

Nigeria is missing more than 76% of its 407,000 people estimated to have developed drug-sensitive TB in 2016. During the same year, more than 93% of its 20,000 people estimated to have developed drug-resistant TB were also missed by the health system.

To find more of its missing people with TB, Nigeria is significantly accelerating the implementation of its public-private mix (PPM) strategy for improving private sector participation in the provision of TB services. The approach will particularly focus on engaging all faith-based organizations, support the expansion of new private for-profit health facilities as well as engage private laboratories, community pharmacists and private medical vendors for TB screening and referral to TB diagnostic facilities. A performance-based model is currently planned to be established. Nigeria is also making use of its Matching Funds through the optimization of 390 GeneXpert facilities across the country to improve efficiencies and diagnostic throughput.

The country is also expanding its active case finding interventions which target slum dwellers in selected big cities as well as internally displaced persons within camps and host communities. Childhood TB case finding is strengthened through the integration of TB services into reproductive, maternal, newborn and child health (RMNACH) services and nutrition clinics. Finally, TB case finding will be strengthened through the establishment of a performance-based funding approach incentivizing the performance of community volunteers. Systematic screening for TB in community settings, as well as scale-up of contact tracing of index TB patients is also being expanded through the Global Fund’s Matching Funds.